StockData

Black Hawk Acquisition Corp (BKHA) stock

BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026Score 5/30
$8.61−0.04 (-0.46%)

Close on Nov 18, 2026Market cap $35.76MP/E –Yield –

Black Hawk Acquisition operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Black Hawk Acquisition's operating income for the twelve months ending Aug 31, 2026 was -$519.49K. For fiscal 2025 it was -$915.51K.

Annual operating income

PeriodPeriod endValueChange
FY2025Nov 30, 2025-$915.51K–
FY2024Nov 30, 2024-$576.08K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Aug 31, 2026-$138.21K–
Q2 FY2026CQ2 2026May 31, 2026-$109.22K–
Q1 FY2026CQ1 2026Feb 28, 2026-$54.19K–
Q4 FY2025CQ4 2025Nov 30, 2025-$217.88K–
Q3 FY2025CQ3 2025Aug 31, 2025-$341.27K–
Q2 FY2025CQ2 2025May 31, 2025-$247.60K–
Q1 FY2025CQ1 2025Feb 28, 2025-$108.77K–
Q4 FY2024CQ4 2024Nov 30, 2024-$101.27K–
Q3 FY2024CQ3 2024Aug 31, 2024-$84.90K–
Q2 FY2024CQ2 2024May 31, 2024-$359.20K–
Q1 FY2024CQ1 2024Feb 29, 2024-$30.70K–

More Black Hawk Acquisition figures

See a number that looks wrong?